Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 74:
75. The compound of claim 73, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2f is C1-C6 alkyl, wherein the C1-C6 alkyl is substituted by 1, 2, 3, 4, or 5 independently selected R2i substituents;
each R2i is independently halogen, C1-C6 alkyl, NR5C(O)R6, NR5C(O)OR6, OR5, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, and 5- to 10-membered heteroaryl is optionally and independently substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents;
each R4a is independently halogen, CN, OR8, or C1-C6 alkyl, wherein each C1-C6 alkyl substituent is optionally and independently substituted by 1 or more independently selected R4b substituents; and
each R4b is an independently selected halogen substituent.